{"organizations": [], "uuid": "3e0c2eb35f2a39f32665baa3b339612aaae7a229", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "http://s3.reutersmedia.net/resources/r/?m=02&d=20151021&t=2&i=1088627511&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXNPEB9K0MK", "site_section": "http://www.reuters.com/news/technology", "section_title": "Technology News | Reuters.com", "url": "http://www.reuters.com/article/2015/10/21/us-biogen-restructuring-idUSKCN0SF1DH20151021", "country": "US", "title": "Biogen to cut 11 percent of global workforce", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "Biogen to cut 11 percent of global workforce | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-10-21T15:45:00.000+03:00", "replies_count": 0, "uuid": "3e0c2eb35f2a39f32665baa3b339612aaae7a229"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/10/21/us-biogen-restructuring-idUSKCN0SF1DH20151021", "ord_in_thread": 0, "title": "Biogen to cut 11 percent of global workforce", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Drugmaker Biogen Inc ( BIIB.O ) said it would cut 11 pct of its global workforce by the end of this year.\nBiogen also reported an 11 percent rise in quarterly revenue, driven by higher demand for its multiple sclerosis drug Tecfidera.\n(Reporting by Rosmi Shaji in Bengaluru)", "external_links": [], "published": "2015-10-21T15:45:00.000+03:00", "crawled": "2015-10-21T14:51:20.333+03:00", "highlightTitle": ""}